Previous 10 | Next 10 |
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2022 financial results on Monday, May 9, 2022. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The confer...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cell programming company Ginkgo Bioworks (NYSE: DNA ) is in the green today on promising new collaboration announcements. DNA stock is up more than 10% heading into market close as investors seem pleased by the n...
More than a building, new headquarters represents Elanco’s endeavor to build a post-COVID workplace destination, the company’s next era of growth an innovation, an expanded downtown Indianapolis that connects the Valley Neighborhood with the Circle, and an epicenter for ...
Elanco Animal Health Incorporated (NYSE: ELAN) (“Elanco”) today announced that as of 5:00 p.m., New York City time, on April 11, 2022 (the “Early Tender Time”), holders of approximately $406,391,000 aggregate principal amount, or approximately 54.19% of the o...
Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology PR Newswire BiomEdit intends to discover and develop animal health products that leverage microbiome science to improve animal health, animal protein production, an...
Jeff Smith’s 13F portfolio value increased from $5.46B to $7.22B this quarter. Starboard Value increased Huntsman Corporation while decreasing Merit Med Systems. They also added GoDaddy, ON Semi, and Colfax while dropping Box Inc. The largest three individual stock position...
Elanco Animal Health Incorporated (NYSE: ELAN) (“Elanco”) today announced the commencement of a cash tender offer (the “Offer”) for up to $250 million aggregate principal amount of its 4.272% Senior Notes due 2023 (CUSIP No. 28414HAE3) (the “Notes ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Elanco’s world-wide animal health business is growing and recession-resistant. Recent acquisitions, i.e., Bayer Animal Health and Kindred Biosciences, are significant positive developments, and combined with reorganizational moves, are beginning to improve financial performance...
Elanco Animal Health (NYSE:ELAN) expands its shared value footprint across Sub-Saharan Africa, delivering on its 2030 pledge to create sustainable development solutions for those who depend on livestock for their livelihoods. Company commits to bringing its comprehensive product portfoli...
News, Short Squeeze, Breakout and More Instantly...
Elanco Animal Health Incorporated Company Name:
ELAN Stock Symbol:
NYSE Market:
Elanco Animal Health Incorporated Website:
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / Feeding dairy cows Bovaer® (3-NOP), Elanco's newest feed ingredient , provides a scalable and credible way for dairy farmers to benefit from being good stewards of the environment by being financially rewarded for implementing on-farm sustaina...
Elanco Confirms Date and Conference Call for Second Quarter 2024 Financial Results Announcement PR Newswire GREENFIELD, Ind. , July 18, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2024 financial results on ...
SAN FRANCISCO, CA / ACCESSWIRE / July 17, 2024 / Hagens Berman urges Elanco Animal Health Incorporated (NYSE:ELAN) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com 844-916-0895 ...